Comparison of pemetrexed plus cisplatin versus pemetrexed plus carboplatin in the initial treatment of locally advanced or metastatic non-small cell lung cancer

被引:0
|
作者
Pereira, A. A. R.
Lessa, R. C.
Souza, C. E. P.
Pinto, F. A. I.
Gagliato, D. M.
Santos, E. S.
Fanelli, M. F.
Rinck, J. A.
Dettino, A. A.
Nicolau, U. R.
Chinen, L. T. D.
de Lima, V. C. C.
Pereira, J. R.
Cruz, M. R. D. S.
机构
[1] Hosp AC Camargo Fund Antonio Prudente, Sao Paulo, Brazil
[2] Hosp AC Camargo Fund Antonio Prudente, Ctr Int Pesquisa & Ensino, Sao Paulo, Brazil
[3] AC Camargo, Sao Paulo, Brazil
[4] Inst Brasileiro Cancerol Toracica, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18067
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer A Phase I Trial
    Heinzerling, John H.
    Choy, Hak
    Hughes, Randall S.
    Govindan, Ramaswamy
    Bradley, Jeffrey D.
    Schwartzberg, Lee S.
    Peng, Guangbin
    Treat, Joseph
    Tran, Taylor
    Obasaju, Coleman
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1391 - 1396
  • [22] Phase I and Pharmacokinetic Study of Pemetrexed plus Cisplatin in Chemonaive Patients with Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non-Small Cell Lung Cancer
    Dickgreber, Nicolas J.
    Fink, Thomas H.
    Latz, Jane E.
    Hossain, Anwar M.
    Musib, Luna C.
    Thomas, Michael
    CLINICAL CANCER RESEARCH, 2009, 15 (01) : 382 - 389
  • [23] A phase I study of pemetrexed plus carboplatin or cisplatin with concurrent chest radiation therapy (CRT) for patients with locally advanced non-small cell lung cancer (LANSCLC)
    Heinzerling, J. H.
    Hughes, R. S.
    Govindan, R.
    Bradley, J. D.
    Schiller, J.
    Peng, G.
    Treat, J.
    Obasaju, C.
    Tran, T.
    Choy, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [26] Pharmacogenetic study of Japanese patients with advanced nonsquamous non-small cell lung cancer treated with pemetrexed plus cisplatin
    Imai, Hisao
    Serizawa, Masakuni
    Takahashi, Toshiaki
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab for Japanese nonsquamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Hayashi, Mina
    Shimizu, Toshiki
    Nomura, Shosaku
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK plus Non-Small Cell Lung Cancer
    Jo, Jaemin
    Kim, Se Hyun
    Kim, Yu Jung
    Lee, Juhyun
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    Chung, Jin-Haeng
    Jeon, Yoon Kyung
    Lee, Jong Seok
    YONSEI MEDICAL JOURNAL, 2018, 59 (02) : 202 - 210
  • [29] Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
    Shen, Xinglei
    DeNittis, Albert
    Werner-Wasik, Maria
    Axelrod, Rita
    Gilman, Paul
    Meyer, Thomas
    Treat, Joseph
    Curran, Walter J.
    Machtay, Mitchell
    RADIATION ONCOLOGY, 2011, 6
  • [30] Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease
    Fujita, Tetsuo
    Kuroki, Tsuguko
    Hayama, Nami
    Shiraishi, Yuka
    Amano, Hiroyuki
    Nakamura, Makoto
    Hirano, Satoshi
    Tabeta, Hiroshi
    Nakamura, Sukeyuki
    IN VIVO, 2019, 33 (06): : 2059 - 2064